EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Prognostic Comparison of Breast Neuroendocrine Neoplasms and Invasive Ductal Carcinoma With Neuroendocrine Differentiation: A Pathology‐Reviewed Cohort and Population‐Based Analysis

Xinke Shi iD, Zihan Yao, Quan Zhou, Yaru Wen, Yaojun Zhai, Dingyuan Wang iD, Jiaqi Liu iD, Bailin Zhang iD

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72467 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Medicine, online erschienen am 11.11.2026. Verfasst von Xinke Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science…. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Ductal, Breast, Neuroendocrine Tumors. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, National High Level Hospital Clinical Research Funding, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast neuroendocrine neoplasms (Br‐NENs) are rare breast tumors with substantial clinicopathological heterogeneity. The prognostic implications of the 2019 World Health Organization (WHO) classification remain incompletely characterized. This study aimed to evaluate the prognostic significance of true breast neuroendocrine neoplasms (NENs) and invasive ductal carcinoma with neuroendocrine differentiation (IDC‐NE) under the 2019 WHO framework.

Methods

We retrospectively analyzed a pathology‐reviewed single‐center cohort of 123 patients, of whom 121 were included in survival analyses, and a separate population‐based cohort of 498 patients from the Surveillance, Epidemiology, and End Results (SEER) database. Institutional cases were reassessed according to the 2019 WHO criteria, whereas SEER tumor groups were defined using registry‐reported International Classification of Diseases for Oncology, Third Edition (ICD‐O‐3) morphology codes. Survival outcomes were compared using Kaplan–Meier analysis and Cox proportional hazards models. Sensitivity analyses were performed to assess robustness, while exploratory propensity score matching (PSM) analyses compared IDC‐NE with conventional invasive ductal carcinoma (IDC).

Results

In the single‐center cohort, true NENs showed more aggressive clinicopathological features and were associated with poorer survival than IDC‐NE. In the SEER cohort, 498 patients were included, comprising 323 with registry‐defined NEN and 175 with registry‐defined IDC‐NE. NEN showed more aggressive characteristics, including a higher rate of distant metastasis at diagnosis. After adjustment for age, stage, year of diagnosis, and race, registry‐defined NEN was independently associated with worse overall survival (hazard ratio [HR] = 1.62, 95% confidence interval [CI] 1.14–2.32) and breast cancer‐specific survival (HR = 2.00, 95% CI 1.30–3.06). Sensitivity analyses yielded consistent results.

Conclusion

Breast NENs were associated with poorer outcomes than IDC‐NE in the pathology‐reviewed cohort. The SEER analysis provided complementary population‐based prognostic evidence for registry‐defined tumor groups. Exploratory PSM analyses did not identify a statistically significant survival difference between IDC‐NE and conventional IDC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, Ductal, BreastNeuroendocrine TumorsHumansFemalePrognosisMiddle AgedSEER ProgramRetrospective StudiesAgedAdultKaplan-Meier Estimate

Stichwörter der Autor:innen

SEER databaseWorld Health Organization classificationbreast neuroendocrine neoplasmsprognosissurvival analysis

Autor:innen und Institutionen

  • Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Thyroid and Breast Surgery, The First People's Hospital of Yangquan, Yangquan, China.
  • Department of Clinical Oncology, Queen Mary Hospital, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.

ORCID-Profile: Xinke Shi, Dingyuan Wang, Jiaqi Liu, Bailin Zhang

Förderung

  • Beijing Municipal Natural Science Foundation
  • National High Level Hospital Clinical Research Funding
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Shi, X., Yao, Z., Zhou, Q., Wen, Y., Zhai, Y., Wang, D., Liu, J., & Zhang, B. (2026). Prognostic Comparison of Breast Neuroendocrine Neoplasms and Invasive Ductal Carcinoma With Neuroendocrine Differentiation: A Pathology‐Reviewed Cohort and Population‐Based Analysis. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72467

Vancouver

Shi X, Yao Z, Zhou Q, Wen Y, Zhai Y, Wang D, et al. Prognostic Comparison of Breast Neuroendocrine Neoplasms and Invasive Ductal Carcinoma With Neuroendocrine Differentiation: A Pathology‐Reviewed Cohort and Population‐Based Analysis. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72467

BibTeX
@article{Shi2026,
  author = {Shi, Xinke and Yao, Zihan and Zhou, Quan and Wen, Yaru and Zhai, Yaojun and Wang, Dingyuan and Liu, Jiaqi and Zhang, Bailin},
  title = {Prognostic Comparison of Breast Neuroendocrine Neoplasms and Invasive Ductal Carcinoma With Neuroendocrine Differentiation: A Pathology‐Reviewed Cohort and Population‐Based Analysis},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cam4.72467}
}
Kostenlos starten →